232 related articles for article (PubMed ID: 9584135)
1. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor.
Kunisada T; Lu SZ; Yoshida H; Nishikawa S; Nishikawa S; Mizoguchi M; Hayashi S; Tyrrell L; Williams DA; Wang X; Longley BJ
J Exp Med; 1998 May; 187(10):1565-73. PubMed ID: 9584135
[TBL] [Abstract][Full Text] [Related]
2. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
Longley BJ; Morganroth GS; Tyrrell L; Ding TG; Anderson DM; Williams DE; Halaban R
N Engl J Med; 1993 May; 328(18):1302-7. PubMed ID: 7682288
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human stem cell factor impairs melanocyte, mast cell, and thymocyte development: a role for receptor tyrosine kinase-mediated mitogen activated protein kinase activation in cell differentiation.
Kapur R; Everett ET; Uffman J; McAndrews-Hill M; Cooper R; Ryder J; Vik T; Williams DA
Blood; 1997 Oct; 90(8):3018-26. PubMed ID: 9376582
[TBL] [Abstract][Full Text] [Related]
4. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
Lee AY; Kim NH; Choi WI; Youm YH
J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
[TBL] [Abstract][Full Text] [Related]
5. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes.
Grabbe J; Welker P; Dippel E; Czarnetzki BM
Arch Dermatol Res; 1994; 287(1):78-84. PubMed ID: 7537033
[TBL] [Abstract][Full Text] [Related]
6. Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes.
Wang Z; Mascarenhas N; Eckmann L; Miyamoto Y; Sun X; Kawakami T; Di Nardo A
J Allergy Clin Immunol; 2017 Apr; 139(4):1205-1216.e6. PubMed ID: 27746235
[TBL] [Abstract][Full Text] [Related]
7. Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors.
Kunisada T; Yoshida H; Yamazaki H; Miyamoto A; Hemmi H; Nishimura E; Shultz LD; Nishikawa S; Hayashi S
Development; 1998 Aug; 125(15):2915-23. PubMed ID: 9655813
[TBL] [Abstract][Full Text] [Related]
8. Altered cell-surface targeting of stem cell factor causes loss of melanocyte precursors in Steel17H mutant mice.
Wehrle-Haller B; Weston JA
Dev Biol; 1999 Jun; 210(1):71-86. PubMed ID: 10364428
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis.
Kunisada T; Yamazaki H; Hirobe T; Kamei S; Omoteno M; Tagaya H; Hemmi H; Koshimizu U; Nakamura T; Hayashi SI
Mech Dev; 2000 Jun; 94(1-2):67-78. PubMed ID: 10842060
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
[No Abstract] [Full Text] [Related]
11. Stem cell factor rescues tyrosinase expression and pigmentation in discreet anatomic locations in albino mice.
Vanover JC; Spry ML; Hamilton L; Wakamatsu K; Ito S; D'Orazio JA
Pigment Cell Melanoma Res; 2009 Dec; 22(6):827-38. PubMed ID: 19682281
[TBL] [Abstract][Full Text] [Related]
12. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.
Imokawa G
Pigment Cell Res; 2004 Apr; 17(2):96-110. PubMed ID: 15016298
[TBL] [Abstract][Full Text] [Related]
13. XPA gene-deficient, SCF-transgenic mice with epidermal melanin are resistant to UV-induced carcinogenesis.
Yamazaki F; Okamoto H; Miyauchi-Hashimoto H; Matsumura Y; Itoh T; Tanaka K; Kunisada T; Horio T
J Invest Dermatol; 2004 Jul; 123(1):220-8. PubMed ID: 15191564
[TBL] [Abstract][Full Text] [Related]
14. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis.
Castells MC; Friend DS; Bunnell CA; Hu X; Kraus M; Osteen RT; Austen KF
J Allergy Clin Immunol; 1996 Oct; 98(4):831-40. PubMed ID: 8876560
[TBL] [Abstract][Full Text] [Related]
15. RIN3 is a negative regulator of mast cell responses to SCF.
Janson C; Kasahara N; Prendergast GC; Colicelli J
PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
[TBL] [Abstract][Full Text] [Related]
16. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
17. The dermal stem cell factor and c-kit are overexpressed in melasma.
Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
[TBL] [Abstract][Full Text] [Related]
18. Guanine Deaminase in Human Epidermal Keratinocytes Contributes to Skin Pigmentation.
Jung JM; Noh TK; Jo SY; Kim SY; Song Y; Kim YH; Chang SE
Molecules; 2020 Jun; 25(11):. PubMed ID: 32517074
[TBL] [Abstract][Full Text] [Related]
19. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia.
Christofidou-Solomidou M; Longley BJ; Whitaker-Menezes D; Albelda SM; Murphy GF
J Invest Dermatol; 1997 Jul; 109(1):102-7. PubMed ID: 9204963
[TBL] [Abstract][Full Text] [Related]
20. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis.
Grichnik JM; Burch JA; Burchette J; Shea CR
J Invest Dermatol; 1998 Aug; 111(2):233-8. PubMed ID: 9699723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
